Stock CLDX CELLDEX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Celldex Therapeutics, Inc.

Equities

CLDX

US15117B2025

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-21 pm EDT 		5-day change 1st Jan Change
37.67 USD -0.21% Intraday chart for Celldex Therapeutics, Inc. -4.56% -5.02%
May. 15 Celldex Therapeutics Reports First Patient Dosed in Phase 2 Skin Disorder Study MT
May. 15 Celldex Therapeutics, Inc. Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CELLDEX THERAPEUTICS, INC. Stock Celldex Therapeutics, Inc.
 2.48B - - -
MODERNA, INC. Stock Moderna, Inc.
 55.07B -
LONZA GROUP AG Stock Lonza Group AG
 40.22B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 41.79B
CELLTRION, INC. Stock Celltrion, Inc.
 28.17B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.28B
  1. Stock Market
  2. Equities
  3. CLDX Stock
  4. Charts Celldex Therapeutics, Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW